Clinical Trials Logo
  1. Home
  2. Genetic Disorders
  3. NCT01401257

Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A

Charcot-Marie-Tooth Disease Clinical Trial

Official title:
A Phase II, Randomized, Placebo-controlled Trial of the Safety, Efficacy, Pharmacodynamics and Pharmacokinetics of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A.

Clinical Trial Summary

The present trial is a randomized, placebo-controlled study evaluating 3 different doses of PXT3003 in patients with CMT1A disease.

Clinical Trial Description

In addition to the safety and tolerability of the treatment, clinical, electrophysiological and biological endpoints (PMP22 mRNA, skin biopsy histology and plasma biomarkers) will be assessed. Standard laboratory tests and drug plasma concentrations will also be measured. Because of the slow progression of the disease and the nature of the observed symptoms, a minimum duration of 12 months of treatment is required in order to observe a potential improvement in any of the efficacy parameters. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01401257
Study type Interventional
Source Pharnext SA
Contact
Status Completed
Phase Phase 2
Start date December 2010
Completion date December 2012
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT06203093 - Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for iPSC Generation and Biobanking
Recruiting NCT03782883 - The Impact of Charcot-Marie-Tooth Disease in the Real World
Recruiting NCT02979145 - Charcot-Marie-Tooth Disease (CMT) Infant Scale (INC-6611) N/A
Terminated NCT03254199 - A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps. Phase 2
Completed NCT02011204 - Study of Electrical Impedance Myography (EIM) in ALS N/A
Completed NCT00149045 - Follow up and Observation of Charcot Marie Tooth Disease in Families N/A
Completed NCT04786522 - Irisin Levels in Patients With Charcot-Marie-Tooth (CMT) Disease
Recruiting NCT05011006 - NT-3 Levels and Function in Individuals With CMT
Recruiting NCT05902351 - Natural History Study for Charcot Marie Tooth Disease
Terminated NCT03943290 - Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX) Phase 2
Active, not recruiting NCT04762758 - Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients Phase 3
Completed NCT02788734 - Patient Reported Outcomes Measures (PROM) in Carpal Tunnel Therapies in Patients With Inherited Neuropathies N/A
Recruiting NCT02532244 - Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases
Terminated NCT05827419 - Hearing and Balance Disorders in Peripheral Neuropathy
Terminated NCT03124459 - Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease Phase 2
Terminated NCT03810508 - A Natural History Study of Charcot-Marie-Tooth 4J (CMT4J)
Recruiting NCT04010188 - A Registered Cohort Study on Charcot-Marie-Tooth Disease
Completed NCT00271635 - Ascorbic Acid Treatment in CMT1A Trial (AATIC) Phase 2
Completed NCT03715283 - Change in MUNIX in Patients With CMT1A Undergoing a Home Ankle Strengthening Program Versus Standard of Care N/A
Completed NCT02001038 - Survey of Current Management of Orthopaedic Complications in CMT Patients N/A